John Saharek
Corporate Officer/Principal at HARROW, INC.
Net worth: 2 M $ as of 30/04/2024
John Saharek active positions
Companies | Position | Start | End |
---|---|---|---|
HARROW, INC. | Corporate Officer/Principal | 01/02/2015 | - |
ImprimisRx LLC | Chief Executive Officer | 02/01/2024 | - |
President | 01/02/2015 | - |
Career history of John Saharek
Former positions of John Saharek
Companies | Position | Start | End |
---|---|---|---|
SURMODICS, INC. | Corporate Officer/Principal | 01/03/2006 | 01/07/2011 |
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Sales & Marketing | - | - |
Training of John Saharek
Central Connecticut State University | Undergraduate Degree |
University of Hartford | Masters Business Admin |
Statistics
International
United States | 7 |
Operational
Corporate Officer/Principal | 2 |
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
SURMODICS, INC. | Health Technology |
HARROW, INC. | Health Technology |
Private companies | 2 |
---|---|
ImprimisRx LLC | |
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Commercial Services |
- Stock Market
- Insiders
- John Saharek
- Experience